Delivery Order SPE2DB20D9354-SPE2DB24FX7Y9

Award Date 9/13/24
Potential Completion Date 10/4/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,814.82, is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which runs through December 31, 2025. The IDC allows...
This federal contract award, valued at $14,002.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order to supply the KYLEENA 19.5 MG SYSTEMS product. DMS Pharmaceutical Group Inc. holds a large indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle, under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,859.07 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,209.88 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, with a period of performance through November 27, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,900.20 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a medical product, with a completion date of June 30, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,209.88, is a firm fixed-price delivery order for the supply of 4565110641 KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product. The contract has an ultimate completion date of July 24, 2024 and was awarded on July 2, 2024. DMS Pharmaceutical Group Inc. holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,006.44 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, which are specialized pharmaceutical products. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,347.24 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, with a period of performance through December 16, 2024. This award is part of a larger $499,999,999 Indefinite Delivery Contract held by DMS Pharmaceutical Group Inc. with the DLA under...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,140.40 firm fixed-price delivery order is for the supply of 4555626854 KYLEENA 19.5 MG SYSTEMS, with a performance period through December 22, 2021. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,024.70 firm fixed-price delivery order is for 4565503730 KYLEENA 19.5 MG SYSTEMS, with a completion date of September 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB24FX7Y9
    Delivery Order

This federal contract award is a delivery order valued at $2,919.35 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the supply of a pharmaceutical product called "KYLEENA 19.5 MG SYSTEMS" and has a performance period through October 4, 2024.

DMS Pharmaceutical Group holds a large indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this and other prime vendor contracts, DMS Pharmaceutical Group provides critical and routine medications to support the diverse medical requirements of the Department of Defense (DoD) and its personnel.

Generated 12/13/24, 9:40 AM